Filings buzz in pharma: 95% increase in digitalization mentions in Q1 of 2022
Novartis referred to digitalization the most between April 2021 and March 2022.
By
Filings
Latest in
Filings
Filings buzz: tracking cybersecurity mentions in pharmaceuticals
We've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
By
Filings buzz in pharma: 60% increase in AI mentions in Q4 of 2021
IQVIA referred to AI the most in 2021, with 26 AI-related sentences in the company's filings.
By
Filings buzz in pharma: 60% increase in AI mentions in Q4 of 2021
IQVIA was the company which referred to artificial intelligence the most during 2021.
By
Filings buzz in pharma: 38% decrease in future of work mentions in Q4 2021
We've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
By
Filings buzz in pharma: 44% increase in big data mentions in Q4 of 2021
We've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
By
Filings buzz in pharmaceuticals: 39% decrease in industrial automation mentions in Q4 of 2021
We've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
By
AstraZeneca mentions industrial automation the most in company filings in Q4 2021
Mentions of industrial automation fell 39% between the third and fourth quarters of 2021.
By